INSIGHTS ON DRUG DEVELOPMENT

• Accelerating Phase: Supply Without Sacrificing Discipline

  Faster clinical supply delivery starts with the right strategy. Explore how planning, collaboration, communication, and quality systems keep programs on track.

• Assess Biomolecular Stability With Confidence

  Gain deeper insight into biomolecular stability with highly sensitive thermal analysis. Thermodynamic measurements help evaluate formulation performance, detect structural changes, and more.

• Advancing Drug Safety And Improving R&D Productivity With The Liver-Chip S1

  Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.

• Why Pharmaceutical Scientists Trust The Discovery Core Rheometer

  Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.

• Your AKTA Oligosynt™ System : It's More Than A Machine

  2/9/2026

  Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.

• Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates

  12/11/2024

  Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.

• An Alternative Method Of Drug-Excipient Characterization

  12/30/2024

  Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.

• Nanomedicine Modalities Find Path To Clinic Through Analytics

  5/16/2025

  Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.

• The Bioprocessing Industry Has A Digital Execution Problem

  8/17/2026

  Digital execution remains a major barrier in manufacturing. Learn how fragmented data, manual decisions, and inconsistent adoption affect the ability to bring complex therapies to patients faster.